Acadia Pharmaceuticals ACAD
NASDAQ ACAD
$22.18 -3.25 (-12.78%)
At close: Sep 24, 2026 · 4:00 PM EDT

Acadia Pharmaceuticals (ACAD) Other Non Operating Income (2018 - 2026)

Acadia Pharmaceuticals (ACAD) posted Other Non Operating Income of $647000.0 for Q2 2026, up 19.37% on a QoQ basis from $542000.0 in Q1 2026, and up 8.92% year-over-year from $594000.0 in Q2 2025.

Analysis

Acadia Pharmaceuticals (ACAD) Other Non Operating Income (2018 - 2026) Analysis & Trends

Acadia Pharmaceuticals has reported Other Non Operating Income for 9 years, with the latest figure at $647000.0 in Q2 2026.

  • On a quarterly basis, Other Non Operating Income rose 8.92% year-over-year to $647000.0 in Q2 2026; TTM through Jun 2026 was $10.6 million, a 43.93% decrease from a year earlier, with the FY2025 full-year figure at $10.6 million, down 42.41% from the prior year.
  • Other Non Operating Income was $647000.0 for Q2 2026 at Acadia Pharmaceuticals, up from $542000.0 in the prior quarter.
  • The five-year high for Other Non Operating Income was $17.2 million in Q4 2024, with the low at -$12.0 million in Q4 2022.
  • Average Other Non Operating Income over 5 years is $1.4 million, with a median of $590500.0 recorded in 2025.
  • The sharpest annual moves came in 2022 and 2024: Other Non Operating Income plunged 379.21% in 2022, then soared 2289.69% in 2024.
  • Over 5 years, Other Non Operating Income stood at -$12.0 million in 2022, then surged by 106.0% to $718000.0 in 2023, then jumped by 2289.69% to $17.2 million in 2024, then slumped by 48.57% to $8.8 million in 2025, then plunged by 92.67% to $647000.0 in 2026.
  • The last three Other Non Operating Income figures came in at $647000.0 (Q2 2026), $542000.0 (Q1 2026), and $8.8 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 649.01 Bn 628.25 Bn 17.26 Bn
2 AbbVie 468.55 Bn 462.03 Bn 12.70 Bn
3 Merck 365.49 Bn 358.40 Bn 12.21 Bn
4 Novartis Ag 272.39 Bn 265.10 Bn 11.24 Bn
5 Astrazeneca 253.18 Bn 247.96 Bn 12.86 Bn
6 Amgen 219.53 Bn 205.54 Bn 7.24 Bn
7 Gilead Sciences 187.85 Bn 184.59 Bn 6.22 Bn
8 Pfizer 160.56 Bn 149.16 Bn 10.94 Bn
9 Vertex Pharmaceuticals 130.81 Bn 122.96 Bn 2.84 Bn
10 Acadia Pharmaceuticals 4.38 Bn 3.42 Bn 279.64 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 647,000.00
Mar 31, 2026 542,000.00
Dec 31, 2025 8.83 Mn
Sep 30, 2025 593,000.00
Jun 30, 2025 594,000.00
Mar 31, 2025 588,000.00
Dec 31, 2024 17.16 Mn
Sep 30, 2024 576,000.00
Jun 30, 2024 386,000.00
Mar 31, 2024 286,000.00
Dec 31, 2023 718,000.00
Sep 30, 2023 1.51 Mn
Jun 30, 2023 -1.24 Mn
Mar 31, 2023 4.85 Mn
Dec 31, 2022 -11.97 Mn
Sep 30, 2022 2.16 Mn
Jun 30, 2022 -497,000.00
Mar 31, 2022 340,000.00
Dec 31, 2021 -12.43 Mn
Sep 30, 2021 383,000.00
API Access

Acadia Pharmaceuticals Other Non Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-operating-income&ticker=ACAD&period=max&api_key=YOUR_API_KEY